Organon Co (OGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Organon Co Stock (OGN) Company Profile

Healthcare (1111)

551-430-6000

30 HUDSON STREET, JERSEY CITY

Nächster Verdiensttermin

Neueste SEC-Einreichungen

OGN's Discussions on Twitter

Compare OGN vs LLY, JNJ, ABBV, AZN, NVS

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OGN Organon Co	7.39	1.84B	6.28B	700.00M	537.00M	2.6922
LLY Lilly Eli Co	1,040.00	929.27B	65.18B	20.64B	6.44B	22.96
JNJ Johnson Johnson	243.45	589.19B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	231.50	402.08B	61.16B	4.20B	19.68B	2.3671
AZN Astrazeneca Plc	205.55	317.06B	58.80B	10.24B	8.98B	3.2788
NVS Novartis Ag Adr	163.10	307.56B	54.72B	14.02B	15.32B	7.1855

Organon Co Stock (OGN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Underweight
2025-10-27	Herabstufung	Piper Sandler	Overweight → Underweight
2025-05-02	Herabstufung	Evercore ISI	Outperform → In-line
2024-09-06	Herabstufung	JP Morgan	Neutral → Underweight
2023-11-03	Herabstufung	Goldman	Buy → Neutral
2023-09-21	Eingeleitet	Barclays	Overweight
2023-03-16	Eingeleitet	Raymond James	Outperform
2022-10-14	Herabstufung	BofA Securities	Neutral → Underperform
2022-09-06	Hochstufung	Piper Sandler	Neutral → Overweight
2022-08-05	Herabstufung	BofA Securities	Buy → Neutral
2022-04-27	Eingeleitet	Goldman	Buy
2022-04-06	Fortgesetzt	Morgan Stanley	Equal-Weight
2021-10-07	Eingeleitet	Piper Sandler	Neutral
2021-09-01	Eingeleitet	BofA Securities	Buy
2021-07-22	Eingeleitet	Citigroup	Buy
2021-06-15	Eingeleitet	JP Morgan	Neutral
2021-06-11	Eingeleitet	Morgan Stanley	Equal-Weight
2021-06-10	Eingeleitet	Evercore ISI	Outperform

Alle ansehen

Organon Co Aktie (OGN) Neueste Nachrichten

Finanzdaten der Organon Co-Aktie (OGN)

Organon Co (OGN)

Organon Co Stock (OGN) Company Profile

Compare OGN vs LLY, JNJ, ABBV, AZN, NVS

Organon Co Stock (OGN) Upgrades & Downgrades

Organon Co Aktie (OGN) Neueste Nachrichten

Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know - Finviz

Organon (OGN) Is Down 12.8% After Earnings Miss And Flat 2026 Outlook Has The Bull Case Changed? - Yahoo Finance

OGN Q4 Deep Dive: Margin Compression and U.S. Headwinds Shape 2026 Outlook - Finviz

Organon & Co. Plans Quarterly Dividend of $0.02 (NYSE:OGN) - MarketBeat

Organon & Co. (NYSE:OGN) Q4 2025 Earnings Call Transcript - Insider Monkey

Assessing Organon (OGN) Valuation After Earnings Miss And Flat 2026 Revenue Guidance - Yahoo Finance

LSV Asset Management Has $83.67 Million Holdings in Organon & Co. $OGN - MarketBeat

Organon Co earnings missed by $0.13, revenue fell short of estimates - Investing.com South Africa

Organon Reshapes Women’s Health Focus With Nexplanon Shift And Jada Sale - Yahoo Finance

Organon Q4 2025 slides: Revenue declines accelerate, stock tumbles on earnings miss By Investing.com - Investing.com South Africa

Organon Q4 2025 slides: Revenue declines accelerate, stock tumbles on earnings miss - Investing.com Canada

Organon & Co. Q4 Earnings Call Highlights - MarketBeat

Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations - The Globe and Mail

Organon & Co To Go Ex-Dividend On February 23rd, 2026 With 0.02 USD Dividend Per Share - 富途牛牛

Organon Earnings Call Balances Stability With Rising Risks - TipRanks

Organon Q3 Net Margin Squeeze Challenges Bullish Earnings Growth Narratives - simplywall.st

Organon Shares Slide on Quarterly Loss and Cautious Outlook - AD HOC NEWS

Organon (OGN) Q4 2025 Earnings Call Transcript - The Globe and Mail

Organon & Co. (NYSE:OGN) Announces Quarterly Earnings Results, Misses Estimates By $0.11 EPS - MarketBeat

Organon: Overview of Fourth Quarter Financial Results - Bitget

Bronstein, Gewirtz & Grossman, LLC Encourages Organon & Co. (OGN) Investors to Inquire about Securities Investigation - ACCESS Newswire

Organon Q4 Earnings ReviewPoor Results Trigger Predictable Sell-Off (NYSE:OGN) - Seeking Alpha

Organon sees FY26 revenue $6.2B, consensus $6.11B - TipRanks

Organon outlines flat $6.2B revenue and $1.9B EBITDA targets for 2026 as cost controls and portfolio shifts take center stage - MSN

Organon reports Q4 adjusted EPS 63c, consensus 73c - TipRanks

Organon Shares Fall After 4Q Earnings Miss Expectations - 富途牛牛

Organon & Co. (NYSE:OGN) Shares Gap Down Following Weak Earnings - MarketBeat

Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

OGN: 2025 results show stable revenue and EBITDA, with 2026 guidance flat amid margin and policy headwinds - TradingView

Organon Co earnings missed by $0.13, revenue fell short of estimates By Investing.com - Investing.com Canada

Earnings call transcript: Organon Q4 2025 reveals EPS miss, stock drops 10.8% - Investing.com

Organon (OGN) Misses Q4 Earnings and Revenue Estimates - Yahoo Finance

Organon falls as women’s health unit drives Q4 miss (OGN:NYSE) - Seeking Alpha

Organon: Q4 Earnings Snapshot - kare11.com

Organon Q4 Adjusted Earnings, Revenue Fall; 2026 Revenue Outlook Issued - 富途牛牛

Earnings snapshot: Organon & Co. misses bottom-line estimates; initiates FY26 outlook - MSN

Organon & Co (NYSE:OGN) Shares Drop on Q4 Earnings Miss and Flat 2026 Outlook - ChartMill

(OGN) Organon Expects 2026 Revenue About $6.22B, vs. FactSet Est of $6.11B - marketscreener.com

Earnings Flash (OGN) Organon Posts Q4 Revenue $1.51B, vs. FactSet Est of $1.54B - marketscreener.com

Organon shares fall over 5% as Q4 earnings miss expectations By Investing.com - Investing.com South Africa

Press Release: Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025 - 富途牛牛

Organon earnings: What to look for from OGN - MSN

Organon Q4 Earnings Preview: Cautious view amid weak year (OGN:NYSE) - Seeking Alpha

Earnings Preview: Organon - Benzinga

Organon & Co. (OGN) Stock Analysis: Exploring A Potential 18.3% Upside In Healthcare - DirectorsTalk Interviews

Organon Earnings: What To Look For From OGN - The Globe and Mail

Organon Q4 Earnings Preview: Revenue Decline Projected Amid Sector VolatilityNews and Statistics - IndexBox

Aug Gainers: Does Organon Co meet Warren Buffetts criteria2025 Momentum Check & Free High Return Stock Watch Alerts - baoquankhu1.vn

Organon & Co. (NYSE:OGN) Stock Price Down 5.2%Here's What Happened - MarketBeat

Down 72% In 3 Years, Can Organon Stock Finally Recover In 2026? - TIKR.com

Organon & Co (OGN.US) will release its earnings report before the market opens on February 12. - 富途牛牛

Finanzdaten der Organon Co-Aktie (OGN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie OGN